[Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)].
A review of the antibacterial activity of 6-[(R)-2-[3-methylsulfonyl-2-oxo-imidazolidine-carboxamido]-2-phenyl-acetamido]-penicillanic acid sodium salt (mezlocillin, Baypen) and 6-[(R)-2-(2-oxo-imidazolidine-1-carboxamido)-2-phenyl-acetamido]-penicillanic acid sodium salt (azlocillin, Securopen) is given on the basis of extensive in vitro studies. The action of each of the preparations is compared with that of important antibiotics of other substance classes from the group of penicillins and cephalosporins.
D001390:Azlocillin; D001419:Bacteria / Q000187:drug effects*; D004754:Enterobacter / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D007709:Klebsiella / Q000187:drug effects; D008802:Mezlocillin; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology*; D011513:Proteus mirabilis / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D001618:beta-Lactamases / Q000378:metabolism
D010406:Penicillins; D001618:beta-Lactamases; D001390:Azlocillin; D008802:Mezlocillin
Die antibakterielle Aktivität von Mezlocillin und Azlocillin. Eine Ubersicht.